The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Update - June 2022

3 Aug 2022 07:00

RNS Number : 6687U
Honeycomb Investment Trust PLC
03 August 2022
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

03 August 2022

Honeycomb Investment Trust plc

Honeycomb Investment Trust plc (the "Company" or "Honeycomb") announces that the Investment Manager's monthly factsheet for 30 June 2022 is now available on its website at http://www.honeycombplc.com.

Net Asset Value per Share

The Company announces that its unaudited Net Asset Value ("NAV") per share as at 30 June 2022 on a cum-income basis was 1,019.7 pence, based on a NAV of £354.2 million, and on an ex-income basis was 1,019.3 pence, based on a NAV of £354.1 million. The NAVs have been calculated by Apex Fund Services (UK) Ltd.

Honeycomb delivered a NAV return of 0.69% for the month, which is equivalent to 8.4% per annum. NAV return was driven by strong risk adjusted yield of 9.2%. Net Investment Assets remained broadly stable in the month at £583m with cash received from the recent Oplo Mortgage Portfolio sale being re-invested.

Pollen Street Credit had another active quarter for deployment completing a number of new transactions and facility upsizes. These include a £65m senior facility to Ark, a Swedish lender focused on providing financing to European technology businesses with each loan benefiting from a 70% principal guarantee from the European Infrastructure Fund; a £65m senior facility to TIER, the leading micro-mobility business in Europe; a £50m senior facility to Splend a vehicle leasing and financing business focused on the ridesharing and delivery driver markets in the UK and Australia; a €50m facility to Earlsfort, a residential development finance lender in Ireland; and we upsized our senior facility to iwoca by £25m, financing their UK SME portfolio. Honeycomb participated in a number of these transactions.

The pipeline of new opportunities is strong with over £400m of transactions in documentation or late stage DD across a range of end subsectors including insurance run off, SME asset backed and probate finance. The broader European pipeline is standing at over £2bn and is well diversified across subsectors and asset classes.

The broader macro environment remains uncertain with a number of risks and concerns with the impact of inflation and higher interest rates the most immediate threat albeit offset somewhat by continuing high levels of employment and rising nominal wages. We are monitoring the performance of the underlying assets closely and we are still seeing very consistent and good performance. We are factoring in the impact of higher prices and interest rates when underwriting and structuring and are also seeing opportunities in sectors with low correlation to the macro. The uncertain environment is also presenting opportunities and we are taking the opportunity to increase returns on new transactions alongside continuing to ensure prudent LTVs such that our investments are able to withstand significant stresses without impairment.

At the General Meeting of the Company held on 1 June 2022, shareholders approved the Company's proposed combination with Pollen Street Capital Holdings Limited ("Pollen Street") (the "Combination"). The Company and Pollen Street are finalising the remaining conditions precedent to complete the Combination within the coming weeks. The key timing dependency for completion is the receipt of remaining change in control approvals from certain regulators with oversight of firms within the Pollen Street Group, and the funds it manages or advises. Pollen Street and the Company have filed all documentation requested by those regulators, and the Financial Conduct Authority and Prudential Regulation Authority approved the change in control on 1 August. The Company will update shareholders when the remaining approvals have been received and completion can proceed.

For further information about this announcement please contact:

Pollen Street Capital - Investment Manager

Matthew Potter / Julian Dale: +44 (0)20 3728 6750

Barclays Bank PLC - Joint Broker

Neal West / Dion Di Miceli / Chris Madderson / Stuart Muress: +44 (0) 20 7623 2323

Liberum Capital Limited - Joint Broker

Chris Clarke: +44 (0)20 3100 2000 

Cenkos Securities plc - Joint Broker

Justin Zawoda-Martin: +44 (0)20 7397 8900

Link Company Matters Limited - Corporate Secretary

hitcosec@linkgroup.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVZLLFBLVLEBBZ
Date   Source Headline
21st Sep 20187:01 amRNSAugust Factsheet
21st Sep 20187:00 amRNSNet Asset Value
5th Sep 20187:00 amRNSDividend Declaration
5th Sep 20187:00 amRNSHalf-year Report 2018
21st Aug 20187:00 amRNSMonthly Update - 31st July 2018
21st Aug 20187:00 amRNSNet Asset Value - 31st July 2018
20th Jul 20187:00 amRNSMonthly Update - Factsheet June 30th 2018
20th Jul 20187:00 amRNSNet Asset Value - June 30th 2018
21st Jun 20183:17 pmRNSNet Asset Value - 31st May 2018 - Replacement
21st Jun 20187:00 amRNSMonthly Update - May 2018
21st Jun 20187:00 amRNSNet Asset Value(s)
8th Jun 20185:42 pmRNSResult of AGM
25th May 20185:29 pmRNSNet Asset Value - 30 April 2018 - Replacement
21st May 20187:00 amRNSNet Asset Value - 30 April 2018
21st May 20187:00 amRNSMonthly Update - 30 April 2018
9th May 20184:28 pmRNSAGM and Financial Statements Notification-Dec 2017
2nd May 20187:00 amRNSHolding(s) in Company
30th Apr 20187:00 amRNSAnnual Report and Audited Financial Statements
25th Apr 20187:00 amRNSHolding(s) in Company - TR1 Announcement
19th Apr 20184:30 pmRNSResult of Placing
19th Apr 20187:00 amRNSProposed Placing
16th Apr 20187:25 amRNSChange of Registered Office
12th Apr 20187:00 amRNSMonthly Update - March 2018
12th Apr 20187:00 amRNSDividend Declaration
12th Apr 20187:00 amRNSNet Asset Value - March 2018
5th Apr 201810:00 amRNSHolding(s) in Company - TR1 Notification
21st Mar 20187:00 amRNSMonthly update - February 28th 2018
21st Mar 20187:00 amRNSNet Asset Value - February 2018
8th Mar 20184:00 pmRNSSupplementary Prospectus
21st Feb 20187:00 amRNSMonthly Update - 31st January 2018
21st Feb 20187:00 amRNSNet Asset Value(s)
21st Feb 20187:00 amRNSDividend Declaration
23rd Jan 20187:00 amRNSHolding(s) in Company - TR1 Notification
22nd Jan 20187:00 amRNSMonthly Update - December 2017
22nd Jan 20187:00 amRNSNet Asset Value(s)
21st Dec 20177:00 amRNSMonthly Update - November
21st Dec 20177:00 amRNSNet Asset Value(s)
28th Nov 20177:00 amRNSHolding(s) in Company - TR-1 Notification
21st Nov 20172:20 pmRNSDividend Declaration - Replacement
21st Nov 20177:00 amRNSMonthly Update - October 2017
21st Nov 20177:00 amRNSNet Asset Value(s) - October 2017
21st Nov 20177:00 amRNSDividend Declaration
16th Nov 20177:00 amRNSHolding(s) in Company - TR-1 Notification
20th Oct 20177:00 amRNSMonthly Update - September 2017
20th Oct 20177:00 amRNSNet Asset Value - September 2017
21st Sep 20177:00 amRNSMonthly update - August 2017
21st Sep 20177:00 amRNSNet Asset Value - August 2017
31st Aug 20177:00 amRNSDividend Declaration - Q2 2017
31st Aug 20177:00 amRNSFinancial Statement Announcement
31st Aug 20177:00 amRNSHalf-year Report 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.